News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sucampo Pharmaceuticals, Inc. to Host Analyst Meeting September 28th


9/17/2012 9:26:11 AM

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced that it plans to host an Analyst Meeting, open to members of the professional investment community, on September 28, 2012, from 8:00 to 11:00 am in New York City. Members of Sucampo’s management team will present detailed descriptions of the Company’s prostone technology, its pipeline of development candidates and provide commercial updates for its two FDA-approved prostone-based drugs, AMITIZA® and RESCULA®.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES